体内
螯合作用
正电子发射断层摄影术
化学
配体(生物化学)
放射化学
类金属
生物物理学
核医学
生物化学
医学
金属
受体
有机化学
生物
生物技术
作者
Aeli P. Olson,Briana R. Schrage,Md Faizul Islam,Lesta S. Fletcher,Francesca Verich,Morgan A. Dierolf,Eduardo Aluicio‐Sarduy,Kaelyn V. Becker,Darren M. Driscoll,Nidhi Girish,Megan E. Simms,Vilmos Kertész,Frankie D. White,Eszter Boros,Alexander S. Ivanov,Jonathan W. Engle,Nikki A. Thiele
出处
期刊:Angewandte Chemie
[Wiley]
日期:2025-01-29
卷期号:64 (15): e202423878-e202423878
被引量:8
标识
DOI:10.1002/anie.202423878
摘要
Abstract Antimony‐119 (119Sb) is one of the most attractive Auger‐electron emitters identified to date, but it remains practically unexplored for targeted radiotherapy because no chelators have been identified to stably bind this metalloid in vivo. In a departure from current studies focused on chelator development for Sb(III), we explore the chelation chemistry of Sb(V) using the tris‐catecholate ligand TREN‐CAM. Through a combination of radiolabeling, spectroscopic, solid‐state, and computational studies, the radiochemistry and structural chemistry of TREN‐CAM with 1XX/natSb(V) were established. The resulting [1XXSb]Sb–TREN‐CAM complex remained intact for several days in human serum, signifying high stability under biological conditions. Finally, the first in vivo single photon emission computed tomography and positron emission tomography imaging studies were carried out using 117Sb, the diagnostic analogue of 119Sb. These studies revealed marked differences in the uptake and distribution of activity in mice administered unchelated [117Sb]Sb(OH)6– versus [117Sb]Sb–TREN‐CAM, suggesting that 117Sb is largely retained by TREN‐CAM over the time course of the study. Collectively, these findings demonstrate the most physiologically stable complex of no‐carrier‐added 1XXSb yet reported, offering new promise for the clinical implementation of radioantimony in nuclear medicine. Our results also establish the feasibility of 117Sb as an elementally matched partner to 119Sb for theranostic applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI